Arthroscopy News and Research RSS Feed - Arthroscopy News and Research

Arthroscopy (also called arthroscopic surgery) is a minimally invasive surgical procedure in which an examination and sometimes treatment of damage of the interior of a joint is performed using an arthroscope, a type of endoscope that is inserted into the joint through a small incision. Arthroscopic procedures can be performed either to evaluate or to treat many orthopaedic conditions including torn floating cartilage, torn surface cartilage, ACL reconstruction, and trimming damaged cartilage.
CyMedica Orthopedics closes $11.5 million Series A financing

CyMedica Orthopedics closes $11.5 million Series A financing

CyMedica Orthopedics, Inc. announced today that it has closed an extension to its Series A financing. The Series A financing was led by investors Research Corporation Technologies, Inc., a Tucson-based venture capital firm, and California Technology Ventures, LLC, a Pasadena-based venture capital fund. The financing also included participation from existing investor Aphelion Capital (Mill Valley, CA) and the founding group of investors. [More]
Omeros signs exclusive license agreement with Fagron affiliates for commercialization of OMS103

Omeros signs exclusive license agreement with Fagron affiliates for commercialization of OMS103

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both large-market as well as orphan indications, today announced that it has entered into an exclusive license agreement with affiliates of Fagron NV for the commercialization of OMS103, Omeros' product for arthroscopic surgery. [More]
BMJ adds new international orthopedic sports medicine journal  to its portfolio

BMJ adds new international orthopedic sports medicine journal to its portfolio

Global healthcare knowledge provider BMJ has added The Journal of ISAKOS: Joint Disorders & Orthopaedic Sports Medicine (JISAKOS) to its extensive portfolio of specialty journals, the company has announced. [More]
CyMedica QB1 System now commercially available for treatment of quadriceps muscle atrophy

CyMedica QB1 System now commercially available for treatment of quadriceps muscle atrophy

Scottsdale-based CyMedica Orthopedics, Inc. announced the commercial launch of the CyMedica QB1 System for the treatment of quadriceps muscle atrophy at the Arthroscopy Association of North American Arthroscopic Society for Sports Medicine annual meeting in Los Angeles last week. [More]
Moirai Orthopaedics receives FDA approval for IDE application to initiate clinical study of PIR System

Moirai Orthopaedics receives FDA approval for IDE application to initiate clinical study of PIR System

Moirai Orthopaedics, L.L.C., an orthopaedic implant development company based in Metairie, Louisiana, is pleased to announce it has received approval from the US Food and Drug Administration for its Investigational Device Exemption (IDE) application to initiate clinical study of the company's Pyrocarbon Implant Replacement (PIR) System. [More]
Pain relief from IA injection may not predict better outcomes following arthroscopic hip surgery

Pain relief from IA injection may not predict better outcomes following arthroscopic hip surgery

How best to treat and recover from complicated hip injuries is a growing field in orthopaedic medicine. While diagnostic hip injections are commonly performed for patients with labral tear to confirm the pain etiology, research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day suggests that pain relief from this diagnostic injection may not predict better outcomes following arthroscopic hip surgery. [More]
NYU Langone becomes first center in New York City to start outpatient hip replacement program

NYU Langone becomes first center in New York City to start outpatient hip replacement program

NYU Langone Medical Center in January became the first academic medical center in the New York City area to initiate an outpatient hip replacement program after successfully discharging a patient the same day of surgery. [More]

DePuy Synthes announces acquisition of Olive Medical

Today DePuy Synthes Companies announced that it has acquired Olive Medical Corporation, a Utah-based privately held provider of high definition (HD) visualization systems for minimally invasive surgery (MIS). Financial terms of the transaction were not disclosed. [More]
CUMC researchers devise way to replace torn knee meniscus

CUMC researchers devise way to replace torn knee meniscus

Columbia University Medical Center researchers have devised a way to replace the knee's protective lining, called the meniscus, using a personalized 3D-printed implant, or scaffold, infused with human growth factors that prompt the body to regenerate the lining on its own. [More]
Orthopedic surgeons recommend prompt medical attention for shoulder dislocations

Orthopedic surgeons recommend prompt medical attention for shoulder dislocations

Prompt and appropriate treatment of a dislocated shoulder--when the head of the upper arm bone (humerus) is completely knocked out of the shoulder socket (glenoid)--can minimize risk for future dislocations as well as the effects of related bone, muscle and nerve injuries, according to a literature review appearing in the December issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS). [More]

GRYPHON PROKNOT Anchor: New hybrid anchor technology for hip and shoulder repair

The DePuy Synthes Companies of Johnson & Johnson has launched GRYPHON Anchors with PROKNOT Technology (GRYPHON PROKNOT Anchors), the first arthroscopic hybrid anchor solution for repair of shoulder and hip instability. [More]

Financial ties between doctors and health firms explored

Federal data shows that doctors and other health care professionals made more than $212 million in speaking and consulting for drug and device makers in the five months at the end of last year, reports The New York Times. [More]
More than 1/3 of planned orthopaedic surgery procedures are re-booked

More than 1/3 of planned orthopaedic surgery procedures are re-booked

More than one third of all planned orthopaedic surgery procedures are re-booked, postponed or cancelled completely. [More]
Activity level predicts how well patients recover from injuries after treatment

Activity level predicts how well patients recover from injuries after treatment

According to a literature review in the July issue of the Journal of the American Academy of Orthopaedic Surgeons, patients' activity level is a strong predictor for how well they will do with certain treatments and how well they recover from injuries after treatment. Patients are encouraged to ask their orthopaedic surgeon if activity level is an important factor in their treatment decision. [More]
FDA grants Thermedx 510(k) clearance for optional fluid warming in arthroscopic, hysteroscopic procedures

FDA grants Thermedx 510(k) clearance for optional fluid warming in arthroscopic, hysteroscopic procedures

Thermedx, LLC, an innovative designer and manufacturer of "smart" surgical irrigation products, received FDA 510(k) clearance for optional fluid warming in arthroscopic and hysteroscopic procedures. [More]
Zimmer issues 5 new patents directed to Subchondroplasty Procedure

Zimmer issues 5 new patents directed to Subchondroplasty Procedure

Zimmer Holdings, Inc. (NYSE and SIX: ZMH) today announced that the United States Patent and Trademark Office has issued five new patents directed to the Subchondroplasty® Procedure, the innovative new joint preservation procedure developed by Zimmer Knee Creations: U.S. Patent No. 8,551,178, U.S. Patent No. 8,574,303, U.S. Patent No. 8,608,802, U.S. Patent No. 8,617,166 and U.S. Patent No. 8,623,089. [More]
eInfochips launches Andromeda Reference Platform for medical imaging and telemedicine designers

eInfochips launches Andromeda Reference Platform for medical imaging and telemedicine designers

The video processing system includes the system hardware and software that design teams need for fast time-to-application development [More]
Viewpoints: Target has the right idea for part-timers; health law 'beyond rescue;' fighting back to secure the right to abortion

Viewpoints: Target has the right idea for part-timers; health law 'beyond rescue;' fighting back to secure the right to abortion

The big noise on the health insurance front today was sounded by Target, which announced via a corporate blog that it's ending health insurance for its part-time workers. Instead of signing up for a company plan, they're encouraged to use the health care exchanges set up through the Affordable Care Act. ... [More]
Single stem cell injection after meniscus knee surgery may provide pain relief, aid in meniscus regrowth

Single stem cell injection after meniscus knee surgery may provide pain relief, aid in meniscus regrowth

​A single stem cell injection following meniscus knee surgery may provide pain relief and aid in meniscus regrowth, according to a novel study appearing in the January issue of the Journal of Bone and Joint Surgery (JBJS). [More]
FIDELITY project compares surgical treatment of degenerative meniscal tears to placebo surgery

FIDELITY project compares surgical treatment of degenerative meniscal tears to placebo surgery

The Finnish Degenerative Meniscal Lesion Study (FIDELITY) compared surgical treatment of degenerative meniscal tears to placebo surgery. [More]
Advertisement
Advertisement